Form EFFECT Quince Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 26, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leerink Starts Quince Therapeutics Inc. (QNCX) at Outperform
- TTW Highlights Top 100 Luxury Hotels in the World for 2026
- Quince Therapeutics (QNCX) Reiterated at Overweight by Cantor Fitzgerald Post Orphai Acquisition
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
